Figure 4. The prevalence of hcmv-miR-UL112-3p was determined using a TaqMan miRNA assay, and the seroprevalence of IgG and IgM against HCMV was detected with ELISA assays in all patients and controls.

HC = Healthy Controls, GBM = Glioblastoma multiforme, RA = Rheumatoid Arthritis and DM = Diabetes Mellitus (patients from the DIGAMI-2 cohort).